A lip biopsy for Sjögren’s syndrome is one of the more accurate tools available for confirming the disease, but it is not as clean-cut as many patients expect. When pathologists look for the hallmark inflammatory pattern, the test picks up roughly 80% of true cases while correctly ruling out non-cases at even higher rates. The complication is that “accurate” depends heavily on what the pathologist looks for, who the patient is, and whether certain confounders are in play. For a test that carries real weight in classification criteria, the nuances matter.
What the Biopsy Actually Measures
During a labial salivary gland biopsy, a surgeon removes several tiny glands from the inside of the lower lip. A pathologist then examines the tissue under a microscope, looking for clusters of immune cells invading otherwise normal gland tissue. The key measurement is the “focus score,” which counts how many dense clusters of 50 or more lymphocytes appear in a standardized area of gland tissue. A focus score of 1 or greater is considered a positive result supporting a Sjögren’s diagnosis.1Frontiers in Immunology. Impression Cytology and In Vivo Confocal Microscopy of Lip Mucosa Compared With Labial Gland Biopsy and Classification Criteria In Patients With Clinically Suspected Primary Sjögren’s Syndrome The pathologist needs at least 4 square millimeters of gland tissue to calculate this score properly, which is why getting an adequate sample matters so much.2Journal of Diagnosis and Treatment of Oral and Maxillofacial Pathology. Correlation and Accuracy of Labial Minor Salivary Gland Biopsy in the Establishment of Diagnosis in Patients with Suspected Sjögren’s Syndrome
In practice, the vast majority of biopsies yield usable tissue. One study of 110 biopsies found that about 98% provided adequate samples for analysis, with only 2 samples falling short. Of the successful biopsies in that cohort, roughly a third came back suggestive of Sjögren’s based on focus score.
Sensitivity, Specificity, and the Numbers Behind Them
The focus score of 1 or higher is the traditional pass/fail line, and by that measure alone, sensitivity for primary Sjögren’s sits around 82%. That means about 18% of people who truly have the disease will get a biopsy that looks negative by this single criterion. Specificity is decent but not exceptional when relying on focus score alone. However, pathologists can look beyond just the focus score. Other tissue features found in Sjögren’s include lymphoepithelial lesions, a shift in the types of plasma cells present, and germinal centers. A study examining these additional features found that while focus score had the highest sensitivity at 82%, the other features each achieved specificity between 98% and 100%.3PubMed. Increased Diagnostic Accuracy of the Labial Gland Biopsy in Primary Sjögren Syndrome When Multiple Histopathological Features Are Included
This means that combining features could substantially improve overall diagnostic accuracy. A biopsy that shows both a positive focus score and lymphoepithelial lesions, for example, is much more convincing than one with a borderline focus score alone. The field is increasingly moving toward evaluating these additional features routinely rather than relying on the focus score as a standalone number.
Where the Biopsy Fits in the Diagnostic Criteria
Under the 2016 ACR-EULAR classification criteria, which are the current international standard, a positive lip biopsy carries heavy weight. The system assigns points across five items, and a patient needs a total of 4 points to meet criteria. A positive biopsy (focus score of 1 or greater) scores 3 points, which is the highest possible score for any single item, tied only with anti-SSA antibody positivity.4PubMed Central. 2016 ACR-EULAR Classification Criteria for primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts This means a positive biopsy alone gets you three-quarters of the way to meeting criteria. Add an abnormal tear test or reduced saliva flow (1 point each), and the threshold is crossed.
This scoring structure reveals something important about when a biopsy is most valuable. If you already have positive anti-SSA antibodies (3 points) plus one abnormal objective test (1 point), you meet criteria without a biopsy. Many rheumatologists will skip the procedure in that scenario. The biopsy becomes indispensable for patients who are antibody-negative but have strong clinical suspicion.
The Seronegative Patient Problem
A meaningful subset of people with Sjögren’s never develop the characteristic antibodies that show up on blood tests. These “seronegative” patients present a diagnostic challenge because their blood work looks unremarkable even while their glands are under autoimmune attack. For these individuals, the lip biopsy is often the only path to a confirmed diagnosis. One case report highlighted exactly this scenario: a patient with all the clinical features of Sjögren’s but no detectable antibodies was diagnosed through the focus score on a labial biopsy.5Bulletin of the National Research Centre. Labial salivary gland biopsy: a crucial method for confirming seronegative Sjogren’s syndrome—a case report
Research has confirmed the connection between antibody status and biopsy results. In a study of patients with suspected Sjögren’s, about 45% of those who tested positive for antinuclear antibodies had suggestive biopsy findings, compared to only 22% of antibody-negative patients.6PubMed Central. Accuracy of Labial Salivary Gland Biopsy in Suspected Cases of Sjogren’s Syndrome That does not mean the biopsy is useless in antibody-negative patients. It means fewer of them will have a positive result, but for the ones who do, the biopsy may be the single most important piece of evidence in their diagnostic puzzle.
The Reliability Gap Between Pathologists
One of the most persistent concerns about lip biopsies is how much the result depends on who reads the slides. Focus scores require a pathologist to identify and count lymphocyte clusters in a specific tissue area, and reasonable professionals can disagree. One study found only 58% complete agreement between pathologists on focus scores, with most disagreement occurring right around the critical threshold between a score of 0 and 1.7PubMed Central. The Value of Labial Gland Biopsies as a Diagnostic Test for Sjögren’s Syndrome That boundary is exactly where the diagnostic stakes are highest.
Digital analysis tools show promise for reducing this variability. In one study comparing conventional microscopy with digital analysis, agreement between observers improved when digital methods were used, with the reliability measure rising from 0.775 to 0.866.8Discover Medicine. Assessment of observer agreement in conventional and digital analysis of salivary gland biopsies in Sjögren’s disease Artificial intelligence models are now being developed to automate focus score evaluation, with the goal of eliminating the subjectivity that plagues manual reading.9PubMed. Evaluation of minor labial salivary gland focus score in Sjögren’s disease using deep learning: a tool for more efficient diagnosis and future tissue biomarker discovery These tools are still emerging, but they address a genuine weakness in the current system.
An older but validated alternative approach uses immunohistochemistry to quantify the types of plasma cells in the biopsy tissue, specifically the proportions producing different antibody classes. This method achieved a sensitivity of 96 to 100% and specificity of 95 to 99% in one study, with excellent reproducibility between observers.10Pathology – Research and Practice. Quantitative immunohistologic study of lip biopsies evaluation of diagnostic and prognostic value in Sjögren’s syndrome Despite these strong numbers, the technique has not been widely adopted in routine practice, partly because it requires extra staining steps that many labs do not perform by default.
Complications and What to Expect
The biopsy is a minor outpatient procedure performed under local anesthesia, and serious complications are uncommon. In a retrospective study of 50 patients, 20% had some form of local complication. These included temporary numbness at the site (6%), pain requiring over-the-counter medication (6%), bruising (6%), and mild inflammation (4%). All issues resolved within days to weeks.11PubMed Central. Local complications associated with labial salivary gland biopsy for diagnosis of Sjögren’s Syndrome: A retrospective cohort study
The more sobering data comes from a larger study of 630 patients, which found that about 21% reported long-standing impaired sensation at the biopsy site that was likely permanent. Younger patients and those without anti-SSA antibodies were more affected. Among those with lasting numbness, the median reported inconvenience was moderate, and about a third said it affected their quality of life to some degree.12PubMed. Complications after minor salivary gland biopsy: a retrospective study of 630 patients from two Swedish centres Interestingly, the rate varied between the two centers studied (14% versus 23%), suggesting that surgical technique and experience play a role.
A meta-analysis of surgical techniques found that the specific incision method matters. Using a minimally invasive punch technique led to roughly four times more total minor adverse events than a linear incision (about 5% versus 1%). However, the rate of permanent or potentially permanent neurological complications was dramatically lower with the minimally invasive approach, at 0.17% compared to 1.45% for linear incisions.13Rheumatology. Neurological adverse events related to lip biopsy in patients suspicious for Sjögren’s syndrome: a systematic review and prevalence meta-analysis In other words, the punch technique trades a higher chance of minor irritation for a much lower risk of lasting nerve damage.
Factors That Can Throw Off the Results
Several factors can make a biopsy misleading, and being aware of them helps you interpret your results more critically.
Age is a significant confounder. As people get older, salivary gland tissue naturally undergoes changes that can mimic Sjögren’s, including increased inflammatory cell infiltration and tissue atrophy. Research suggests that elderly patients who lack anti-SSA antibodies are at risk of a false-positive diagnosis if the biopsy is interpreted based on focus score alone, because their biopsies tend to lack the lymphoepithelial lesions that are more specific to actual Sjögren’s.14Arthritis & Rheumatology. Elderly Patients Risk a False Positive Diagnosis of Primary Sjogren’s Syndrome If a Positive Labial Gland Biopsy Is Solely Based on Focus Score Some investigators have found that higher focus scores in people over 65 can simply reflect the aging process rather than autoimmune disease.15Revista Colombiana de Reumatología. Questions as regards the recognition of elderly-onset primary Sjögren’s syndrome: Where we are and where we would rather be
Smoking is another confounding factor that works in the opposite direction. Current smokers with Sjögren’s are significantly less likely to show the characteristic focal lymphocytic pattern on biopsy, with roughly a quarter the odds of showing it compared to non-smokers. Instead, smokers tend to show a more diffuse, non-specific type of inflammation that does not meet the criteria for a positive focus score.16PLOS ONE. Effect of Tobacco Smoking on The Clinical, Histopathological, and Serological Manifestations of Sjögren’s Syndrome This means smoking can mask the disease on biopsy, potentially leading to a false-negative result.
Immunosuppressive medications are a third confounder. Corticosteroid treatment has been shown to reverse some of the histological abnormalities seen in Sjögren’s biopsies, meaning a patient who undergoes biopsy while on these medications could get a misleadingly negative result.17PubMed Central. Reversibility of histological and immunohistological abnormalities in sublabial salivary gland biopsy specimens following treatment with corticosteroids in Sjögren’s syndrome One study found that when patients who had been on immunosuppression for more than six weeks before biopsy were excluded, the correlation between biopsy results and clinical diagnosis strengthened.18PubMed. The minor salivary gland biopsy as a diagnostic tool for Sjogren syndrome If you are on corticosteroids or other immunosuppressive drugs, your doctor should factor this into the timing and interpretation of the procedure.
Can Ultrasound Replace the Biopsy?
Salivary gland ultrasound has gained traction as a non-invasive alternative, and the concordance data is striking. In one study of 85 patients with dry mouth and dry eye symptoms, ultrasound of the major salivary glands agreed with biopsy results 91% of the time. The negative predictive value was 96%, meaning a normal-looking ultrasound made a positive biopsy very unlikely.19PubMed. Ultrasound of the salivary glands is a strong predictor of labial gland biopsy histopathology in patients with sicca symptoms Another study found slightly higher agreement between ultrasound and parotid gland biopsy than between ultrasound and labial biopsy.20PubMed. Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjögren’s syndrome
That 96% negative predictive value is clinically useful as a screening step. If the ultrasound looks completely normal, many clinicians feel comfortable skipping the biopsy, especially in patients who already have positive anti-SSA antibodies. But ultrasound has not been incorporated into the formal 2016 classification criteria, and a positive ultrasound alone does not replace tissue confirmation in ambiguous cases.
Parotid Gland Biopsy as an Alternative
Some centers have explored biopsying the parotid gland instead of the lip. One comparison found that parotid and labial biopsy had similar sensitivity (78%) and specificity (86%), with comparable levels of pain. The significant difference was in neurological complications: no permanent sensory loss occurred after parotid biopsy, while 6% of labial biopsy patients experienced lasting numbness.21Rheumatology. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjögren’s syndrome The parotid approach remains less common, partly because it requires more surgical expertise and carries a theoretical risk to the facial nerve, but the data suggests it deserves consideration, especially for patients concerned about lip numbness.
Children and Sjögren’s
Pediatric Sjögren’s is a different diagnostic challenge. There are no child-specific classification criteria, so clinicians adapt adult tools, including the lip biopsy. A systematic review of 39 studies on pediatric cases found that the biopsy yielded positive findings in about 70% of affected children.22PubMed. Clarifying the Diagnostic Pathway in Pediatric Sjögren’s Syndrome in the Absence of Child-Specific Criteria: A Systematic Review That is somewhat lower than the roughly 82% sensitivity seen in adults, though direct comparison is difficult given the smaller and more heterogeneous study populations in pediatric research. Children with Sjögren’s also tend to present differently, with recurrent parotid gland swelling being the most common glandular symptom rather than the dry eyes and dry mouth that dominate in adults.
Beyond Diagnosis: What the Biopsy Can Predict
The lip biopsy turns out to carry prognostic information that goes beyond a simple yes-or-no diagnosis. One of the more concerning risks of Sjögren’s is the development of lymphoma, and biopsy features can help gauge that risk. Germinal centers, which are organized structures of immune cells that form within the gland tissue, are found in roughly a quarter of Sjögren’s biopsies. Patients whose biopsies show germinal centers tend to have more severe disease, with higher antibody levels and reduced saliva production. They also face a substantially elevated lymphoma risk, around 14% compared to 1% in patients without germinal centers.23Seminars in Arthritis and Rheumatism. The Role of Ectopic Germinal Centers in the Immunopathology of Primary Sjögren’s Syndrome: A Systematic Review
The focus score itself, independent of germinal centers, has been identified as a predictor of lymphoma risk. Research has shown that the focus score at the time of diagnosis is an independent risk factor for developing Sjögren’s-associated lymphoma, potentially serving as an early warning biomarker.24PubMed. A biomarker for lymphoma development in Sjogren’s syndrome: Salivary gland focus score This dual role, diagnostic and prognostic, is one of the strongest arguments for performing the biopsy even in patients who might meet classification criteria through other means.
Whether Repeat Biopsies Add Anything
Patients sometimes wonder whether a follow-up biopsy might be useful, either to track disease progression or to catch something the first biopsy missed. The evidence suggests this is rarely worthwhile. A follow-up study of patients who underwent repeat minimally invasive lip biopsies found that the histological diagnosis changed in only about 1.6% of cases.25PubMed. A follow-up study of minimally invasive lip biopsy in the diagnosis of Sjögren’s syndrome Repeated biopsy very rarely adds new information, which makes sense given that the inflammatory infiltration in Sjögren’s tends to be stable or progressive rather than fluctuating. A negative first biopsy in someone with ongoing symptoms is better addressed by looking at the clinical picture more broadly than by repeating the same test.